Biliary Tract Cancer
📧 Sign up to get email alerts when something new happens for Biliary Tract Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer [Phase 3]
A Phase 3 clinical trial comparing AK112 plus chemotherapy to Durvalumab plus chemotherapy in advanced biliary tract cancer; the trial is cu…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment [Phase 2]
Phase 2 clinical trial evaluating lenvatinib plus paclitaxel in patients with advanced biliary tract cancer after gemcitabine-based therapy;…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Biliary Tract Cancers [Phase 2]
A Phase II trial is evaluating organoid drug sensitivity testing to guide therapy for unresectable biliary tract cancers, with the study cur…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400 [Phase 1]
Phase 1 study assessing adverse events and change in disease activity in adults with select advanced solid tumors treated with ABBV-400; the…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating CTX-009 in combination with gemcitabine, cisplatin, and durvalumab as first-line therapy for unresecta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer
An update on the Registry of Genetic Alterations of Taiwan Biliary Tract Cancer, sponsored by the National Health Research Institutes, Taiwa…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers [Phase 1]
Phase 1 clinical trial evaluating Palliadelic treatment to reduce psychological distress in people with advanced pancreatic and biliary trac…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: A Phase 1 Study of LNCB74 in Advanced Solid Tumors [Phase 1]
Status update for a Phase 1 study of the investigational agent LNCB74 in patients with various advanced solid tumors, including ovarian, bre…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: An Exploratory Study on the Use of Ivosidenib for the Precise Treatment of Advanced Biliary Tract Malignancies With IDH1 Mutations in the Later Line of Therapy. [Phase 2]
An exploratory Phase 2 study assessing the use of ivosidenib for IDH1-mutant biliary tract cancers in later lines of therapy.
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: The Study of Association of Helicobacter Infections in Biliary Tract Cancers
A clinical trial update from Institute of Liver and Biliary Sciences, India, studying the association of Helicobacter infections in biliary …
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: A Study of MT-4561 in Patients With Various Advanced Solid Tumors [Phase 1, Phase 2]
This trial update reports that MT-4561 is being studied in multiple advanced solid tumors across Phase 1/Phase 2 and is currently recruiting…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer [Phase 1]
A Phase 1 clinical trial evaluating chemoimmunotherapy combined with hyperthermia and spatially-fractionated radiotherapy in advanced biliar…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Pembrolizumab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer [Phase 2]
A Phase 2 trial is examining pembrolizumab alone or with lenvatinib or chemotherapy as first-line treatment for advanced biliary tract cance…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Tuvonralimab and Iparomlimab Based Regimens for the Neoadjuvant Treatment of Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial update evaluating regimens based on Tuvonralimab and Iparomlimab for the neoadjuvant treatment of biliary tract cance…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC) [Phase 1]
A Phase 1 clinical trial is evaluating a peptide vaccine targeting driver oncogenes in combination with durvalumab and tremelimumab for bili…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Iparomlimab and Tuvonralimab Injection Combined With GemOX and Lenvatinib as Conversion Therapy for Initially Potentially Resectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of iparomlimab and tuvonralimab with GemOX chemotherapy and lenvatinib as conversion thera…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers [Phase 2]
Phase 2 perioperative regimen of gemcitabine, cisplatin, and pembrolizumab for potentially resectable biliary tract cancers; sponsored by Jo…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) [Phase 1, Phase 2]
Spevatamig (PT886) is being studied as a monotherapy or in combination with chemotherapy and/or immune checkpoint inhibitors in Phase 1/2 tr…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers
This clinical trial protocol from the University of Nottingham aims to characterize biliary strictures and hepatobiliary–pancreatic focal le…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
University of Chicago is recruiting for a tissue procurement study across multiple cancers in patients undergoing surgery or biopsy to colle…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) [Phase 1, Phase 2]
This clinical trial update reports Eli Lilly's KRAS G12C inhibitor LY3537982 is being studied in Phase 1/2 trials across multiple KRAS G12C-…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery [NA]
Clinical trial update indicating ongoing recruitment for a study on optimal perioperative pain control in minimally invasive abdominal cance…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: XmAb20717 in Advanced Biliary Tract Cancers [Phase 2]
Phase 2 clinical trial update for XmAb20717 in advanced biliary tract cancers, currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer
A CHA University-sponsored clinical trial (NCT06893380) is evaluating the combination of GCNT and tislelizumab in locally advanced or metast…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Yueju Pill Combined With Standard Therapy In Advanced Biliary Tract Cancer [NA]
This document notes a clinical trial evaluating Yueju Pill in combination with standard therapy for advanced biliary tract cancer, with the …